How can we best prevent pertussis in infants?

Clinical Infectious Diseases

Volumn 54, Issue 1, 2012, Pages 85-87

  Libster, Romina ^a,b   Edwards, Kathryn M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Fundación INFANT ^*  (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

COMPUTER SIMULATION; HUMAN; IMMUNIZATION; INFANT; INFECTION PREVENTION; NOTE; PERTUSSIS; PRIORITY JOURNAL; PUERPERIUM;

DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HUMANS; IMMUNIZATION; MALE; WHOOPING COUGH;

EID: 84555170740     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir780     Document Type: Note

References (14)

1. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR Morb Mortal Wkly Rep 2011; 60:13-5.
2. California Department of Public Health. Pertussis report. August 10, 2011. 2011. Available at: http://www.cdph.ca.gov/programs/immunize/Documents/ Pertussis-Report2011-08-10.pdf. Accessed 5 September 2011.
3. Centers for Disease Control and Prevention (CDC). Pertussis (whooping cough). Outbreaks. 2011. Available at: http://www.cdc. gov/pertussis/outbreaks. html. Accessed 5 September 2011.
4. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004; 23:985-9. (Pubitemid 40824285)
5. Castagnini LA, Munoz FM. Clinical characteristics and outcomes of neonatal pertussis: a comparative study. J Pediatr 2010; 156: 498-500.
6. Van Rie A, Hethcote HW. Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine 2004; 22:3154-65. (Pubitemid 39037219)
7. Broder KR, Cortese MM, Iskander JK, et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2006; 55:1-34.
8. Castagnini LA, Healy MC, Rench MA, Wootton SH,Munoz FM, Baker CJ. Impact of maternal postpartum tetanus diptheria toxoids and acellular pertussis immunization of infant pertussis infection. Clin Infect Dis 2011; 54:78-84.
9. Kirkland KB, Talbot EA, Decker MD, Edwards KM. Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control. Clin Infect Dis 2009; 49:584-7.
10. ACIP provisional recommendations for pregnant women on use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap). Available at: http://www.cdc.gov/vaccines/recs/provisional/downloads/pregnant- Tdap-use.pdf. Accessed 5 September 2011.
11. Healy CM, Munoz FM, Rench MA, Halasa NB, Edwards KM, Baker CJ. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis 2004; 190:335-40. (Pubitemid 38951975)
12. Healy CM, Rench MA, Edwards KM, Baker CJ. Pertussis serostatus among neonates born to Hispanic women. Clin Infect Dis 2006; 42:1439-42.
13. Van Savage J, Decker MD, Edwards KM, Sell SH, Karzon DT. Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis 1990; 161: 487-92. (Pubitemid 20107950)
14. Englund JA, Anderson EL, Reed GF, et al. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 1995; 96: 580-4.